More Good News for The Baha System, a Bone Anchored (Osseointegrated) Implant
At the recently concluded 10th International Conference on Cochlear Implants and Other Implantable Auditory Technologies held in San Diego, California on April 10 – 12, a group of investigators from the Loyola University Chicago presented generally positive clinical results from the study of patients implanted with the Baha® bone conduction implant from Cochlear. The device is not a new one. It was cleared by the FDA in 1996 as a treatment for conductive and mixed hearing loss. (At that time, the device was made by Entific Medical Systems, which was later acquired by Cochlear.) And since 2002, the device has been approved by the FDA for the treatment of unilateral sensorineural hearing loss.